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Abstract
Background: There is increasing epidemiological and experimental evidence for an aggravating
effect of particulate air pollution on asthma and allergic symptoms and, to a lesser extent, on allergic
sensitization. Genetic factors appear to influence not only the magnitude, but also the quality of the
adjuvant effect of particles with respect to allergen-specific IgE (Th2-associated) and IgG2a (Th1-
associated) responses. In the present study, we aimed to investigate how the genetic background
influences the responses to the allergen and particles alone and in combination. We examined how
polystyrene particles (PSP) affected the IgE and IgG2a responses against the model allergen
ovalbumin (OVA), after subcutaneous injection into the footpad of BALB/cA, BALB/cJ, NIH and
C3H/HeN mice, Further, ex vivo IL-4, IFN-γ  and IL-10 cytokine secretion by Con A-stimulated cells
from the draining popliteal lymph node (PLN) five days after injection of OVA and PSP separately
or in combination was determined.
Results: PSP injected with OVA increased the levels of OVA-specific IgE antibodies in all strains
examined. In contrast, the IgG2a levels were significantly increased only in NIH and C3H/HeN
mice. PSP in the presence of OVA increased cell numbers and IL-4, IL-10 and IFN-γ  levels in BALB/
cA, NIH and C3H/HeN mice, with the exception of IFN-γ  in NIH mice. However, each mouse
strain had their unique pattern of response to OVA+PSP, OVA and PSP, and also their unique
background cytokine response (i.e. the cytokine response in cells from mice injected with buffer
only).
Conclusion: Genetic factors (i.e. the strain of mice) influenced the susceptibility to the adjuvant
effect of PSP on both secondary antibody responses and primary cellular responses in the lymph
node, as well as the cellular responses to both OVA and PSP given separately. Interestingly, PSP
alone induced cytokine responses in the lymph node in some of the mouse strains. Furthermore,
we found that the ex vivo cytokine patterns did not predict the in vivo Th2- and Th1-associated
antibody response patterns in the different mouse strains. The results indicate that insoluble
particles act by increasing the inherent response to the allergen, and that the genetic background
may determine whether an additional Th1-associated component is added to the response.
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Background
Numerous epidemiological studies conducted in different
parts of the world have demonstrated a consistent associ-
ation between levels of ambient air particles and various
health outcomes, including mortality, cardiopulmonary
disease, reduced lung function, and exacerbation of
asthma and allergy-related symptoms (reviewed in [1,2]).
Some populations seem to be at particular risk, like the
elderly, children or patients with diabetes, chronic
obstructive pulmonary disease and asthma [1,3]. Further-
more, the genetic background has been associated with
differences in human susceptibility to environmental
agents including pesticides and infectious agents [4], and
may be of importance also with regard to biological effects
of particles.
Supporting a causal relationship between particles and
increased allergic symptoms, particles have been shown to
increase allergic responses both in humans and in animal
models (reviewed in [5,6]). In rodent models, widely dif-
ferent particles have been shown to increase allergen-spe-
cific IgE levels both after inhalation, intratracheal,
intranasal, intraperitoneal and subcutaneous exposure [7-
12]. Particle characteristics like particle size, particle com-
position and chemicals adsorbed to the particle surface
have been shown to influence the adjuvant effect on aller-
gic sensitization and airway inflammation and hyperreac-
tivity in mice [11-18]. For combustion particles, the
insoluble particle core appears to play an important role
in the adjuvant effect of particles in several mouse models
[18-23]. Mouse strain differences in allergic airway
inflammation and allergen-specific antibody levels have
been reported after intratracheal instillation of diesel
exhaust particles (DEP) and allergen [24,25]. Also with
"clean" polystyrene particles (PSP, 0.1 µm diameter) as a
surrogate of the insoluble combustion particle core, Gra-
num et al. [26] concluded that the particle adjuvant effect
differed qualitatively with regard to Th2- and Th1-associ-
ated antibody responses, depending on the genetic back-
ground or induced immune status of the mice.
The overall aim of the present study was to investigate
how the genetic background influences the responses to
the allergen and particles alone and in combination. We
therefore examined the antibody and lymph node
responses in various inbred strains of mice expected to
display different responses to OVA and particles. BALB/cA
mice are regarded as a high IgE responder strain to OVA
[27,28]. NIH mice were included because they in an intra-
peritoneal model responded differently from BALB/cA
mice to PSP and OVA [26]. Furthermore, we included
C3H/HeN mice, which have been shown to be IgE low-
responders to OVA [28]. BALB/cJ mice were included in
the antibody experiments because this sub-strain has been
reported to respond more strongly to OVA than BALB/cA
mice in a subcutaneous model [29].
The lymph node is a key site in the priming of T lym-
phocytes and IgE production by B lymphocytes
[11,30,31]. Therefore, in addition to serum antibody lev-
els, we examined the primary cellular response in the
draining popliteal lymph node (PLN) after footpad injec-
tion of polystyrene particles (PSP) and the allergen oval-
bumin (OVA), alone and in combination. The PLN is the
only lymph node draining the footpad [32], and is there-
fore well suited for studies of responses in the lymph node
cells. We investigated how the selected inbred strains of
mice differed qualitatively and quantitatively in their Th2-
and Th1-associated serum antibody and PLN cellular
response patterns to OVA+PSP. Furthermore, we investi-
gated if the background (i.e. the ex vivo cytokine response
in cells from mice injected with buffer only), OVA-, PSP-
and OVA+PSP-induced cytokine patterns differed in the
various mouse strains, and whether the cytokine patterns
could explain the differences in the antibody responses to
OVA+PSP. We found that the susceptibility to the adju-
vant effect of particles on both secondary antibody
responses and primary cellular responses was influenced
by genetic factors (i.e. mouse strain). The ex vivo cytokine
response patterns did not predict the in vivo antibody
responses.
Results
The antibody adjuvant activity of PSP in different strains 
of mice
To examine the dose-response relationship of OVA and
PSP with regard to antibody production, BALB/cA and
NIH mice were immunized with various dose combina-
tions of OVA (100, 50 and 10 µg) and PSP (100, 40, 10
and 0 µg). After a booster dose of OVA on day 21, the
OVA-specific IgE, IgG1 and IgG2a antibody levels in
serum were determined on day 26. In BALB/cA mice, PSP
given with OVA strongly increased the levels of the Th2-
associated IgE and IgG1 antibodies compared to OVA
alone (Figure 1A, B). In contrast, the Th1-associated IgG2a
levels did not differ between the groups given OVA in the
presence or absence of PSP (Figure 1C). Overall, there was
an inverse relationship between the OVA dose and both
the IgE and IgG1 levels, with 10 µg of OVA giving the
highest antibody levels for all particle doses. Analyses of
the factorial design showed that the dose of 10 µg OVA,
regardless of PSP dose, induced significantly higher IgE
levels than the other OVA doses, and higher IgG1 levels
than 100 µg OVA (p < 0.001). Irrespective of OVA dose,
the IgG1 response increased significantly with each
increase in PSP dose (p < 0.001). A dose-response trend
for particles was less clear for IgE due to an absence of a
difference between 40 and 100 µg PSP.BMC Immunology 2005, 6:11 http://www.biomedcentral.com/1471-2172/6/11
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In NIH mice, PSP also exerted an adjuvant effect on the
antibody responses to OVA, however NIH mice
responded differently from BALB/cA mice in two ways.
First, the NIH mice receiving the highest dose combina-
tions of OVA and PSP experienced anaphylactic reactions
and died within minutes after the OVA booster injection
(indicated with crosses in Figure 1D, E, F). Secondly, also
the OVA-specific IgG2a levels were increased by PSP in
NIH mice, in contrast to BALB/cA mice. However, the
responses in the surviving mice (i.e. 10 µg OVA) suggest
that IgE and IgG1 responses were similar in NIH and
BALB/cA mice with regard to the dose-response relation-
ship for particles. Also the IgG2a levels were significantly
higher for OVA with all particle doses than for OVA alone,
and significantly higher antibody levels were observed
with 40 µg PSP than with 10 µg PSP.
Allergen and particle dose-response experiments in BALB/cA and NIH mice Figure 1
Allergen and particle dose-response experiments in BALB/cA and NIH mice Levels of serum OVA-specific IgE (A, 
D), IgG1 (B, E) and IgG2a (C, F) on day 26 after injection into one hind footpad of 100 (open columns), 50 (gray) or 10 (black) 
µg OVA combined with 100, 40, 10 or 0 µg PSP, or buffer (HBSS (hatched)), in BALB/cA (A, B, C) and NIH (D, E, F) mice. On 
day 21 the mice were boostered with the same OVA dose in the footpad. The PSP-control ("PSP ctr") group was given 100 µg 
PSP on day 0, followed by HBSS injection on day 21 (diamonds). Values (arbitrary units, AU) for individual mice (circles) and 
median values (columns) for groups of eight mice are shown. Dotted lines indicate the lower or higher detection limits for the 
ELISA assays. Note different scales for the two strains of mice.
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As 10 µg OVA and 40 µg PSP gave a medium but still pro-
nounced response, these doses were used in further exper-
iments. Next, we compared the allergen-specific antibody
responses after immunization with OVA+PSP, OVA and
PSP in BALB/cA, BALB/cJ, NIH and C3H/HeN mice. As
shown in Figure 2, the response patterns for BALB/cA and
NIH mice were similar to those shown in Figure 1, with
increased IgE production in both strains, whereas IgG2a
production was increased only in NIH mice. Furthermore,
in our system, BALB/cJ mice had specific IgE and IgG2a
responses similar to BALB/cA mice, however the IgG2a
levels tended to be slightly increased by OVA+PSP in
BALB/cJ mice (statistically significant in one of two exper-
iments). Similar to the responses in NIH mice, PSP had an
adjuvant effect on both IgE and IgG2a responses in C3H/
HeN mice, although the responses appeared weaker in
C3H/HeN than in NIH and BALB/c mice.
Immunization with OVA alone gave IgE responses in
some individual BALB/cA, BALB/cJ and C3H/HeN mice,
but never in NIH mice (Figure 1 and 2). As expected, HBSS
and PSP without allergen did not affect the specific anti-
body levels in any of the strains.
Cell numbers and ex vivo cytokine responses in the 
draining lymph node during the primary response
To examine how the primary cellular response to OVA
and PSP, alone or in combination, varied in BALB/cA,
NIH and C3H/HeN mice, we studied the cell numbers
and the ex vivo cytokine secretion by the popliteal lymph
The adjuvant effect of PSP on OVA-specific IgE and IgG2a responses in different strains of mice Figure 2
The adjuvant effect of PSP on OVA-specific IgE and IgG2a responses in different strains of mice Levels of serum 
OVA-specific IgE (A) and IgG2a (B) on day 26 after injection into one hind footpad of HBSS (open columns), 10 µg OVA (gray), 
40 µg PSP (hatched) or 10 µg OVA + 40 µg PSP (black) in different mouse strains. On day 21 all mice were boostered with 10 
µg OVA in the footpad. Vertical straight lines indicate separate experiments. Values (arbitrary units, AU) for individual mice 
(circles) and median values (columns) for groups of mice are shown. Dotted lines indicate the lower detection limits for the 
ELISA assays. Brackets indicate statistically significant differences between groups (p < 0.05). All experiments were performed 
twice with similar results, with eight mice per group.
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node (PLN) cells. Five days after injection of OVA+PSP,
OVA, PSP and buffer (HBSS) into the footpad, the PLN
cell numbers were determined, and the amount of IL-4,
IFN-γ  and IL-10 released from PLN cells after Con A stim-
ulation ex vivo were determined.
For all three strains, the PLN cell numbers were signifi-
cantly increased by OVA+PSP compared to all three con-
trol groups (Figure 3A). Interestingly, the cell number
response to OVA alone and PSP alone (compared to
HBSS) varied between the three strains. In BALB/cA mice,
OVA significantly increased the cell numbers, whereas
PSP significantly increased the cell numbers in NIH mice.
C3H/HeN mice took an intermediate position, as both
OVA and PSP weakly but significantly increased the cell
numbers compared to HBSS.
With regard to the cytokines (Figure 3B, C and 3D),
OVA+PSP strongly increased the levels of IL-4 and IL-10
compared to the three control groups in BALB/cA mice (p
< 0.006), whereas the IFN-γ  levels were only marginally
affected (p < 0.035). Furthermore, OVA tended to weakly
(n.s.) increase the IL-4 levels in BALB/cA mice. The IL-4
levels for the BALB/cA control groups were relatively low
compared to levels in NIH mice. In NIH mice, OVA
induced no changes in cytokines or cell numbers, whereas
The primary cellular response in the draining lymph node Figure 3
The primary cellular response in the draining lymph node The primary cellular response in the draining PLN was 
determined five days after a single injection of HBSS (open columns), 10 µg OVA (gray), 40 µg PSP (hatched) or 10 µg OVA + 
40 µg PSP (black) into both hind footpads of BALB/cA, NIH and C3H/HeN mice. The total lymph node cell numbers (A) and 
IL-4 (B), IFN-γ  (C) and IL-10 (D) secreted from the PLN cells after ex vivo stimulation with Con A were determined. Values for 
individual samples (circles) and group median values (columns) are shown. Dotted lines indicate the lower detection limits for 
the cytokine ELISA assays, and brackets indicate statistically significant differences between groups (p < 0.05).
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PSP significantly increased the IL-4 and IL-10 levels (p <
0.007), and OVA+PSP also increased these "responsive"
cytokines (p < 0.005, compared to OVA). The IFN-γ  levels
in NIH mice were not altered by PSP. Again, the C3H/
HeN mice responded to both OVA and PSP. All cytokines
were significantly increased by OVA and further increased
by OVA+PSP in C3H/HeN mice, although more pro-
nounced for IFN-γ  than for IL-4 and IL-10. PSP alone also
significantly increased the levels of IFN-γ  and IL-10 in
C3H/HeN mice. The levels of IL-4 and IL-10 were low and
the levels of IFN-γ  were high in C3H/HeN mice compared
to the levels in the other strains. The background levels
(buffer treated animals) of IL-4 and IFN-γ  were relatively
low in BALB/cA and relatively high in NIH mice, whereas
the levels in C3H/HeN mice appeared low for IL-4 and
high for IFN-γ , respectively.
Discussion
The genetic background appears to strongly influence
whether an individual develops allergic immune
responses to an allergen [33]. In mice, this is illustrated by
reports of strain differences in allergic responses to aller-
gens [28,34-36]. In agreement with Granum et al. [26],
our data indicate that also the antibody-enhancing capac-
ity of the "clean" insoluble particle is influenced by the
genetic background. This is consistent with reports of
mouse strain differences in allergic airway inflammation
and specific antibody levels after intratracheal instillation
of DEP and allergen [24,25]. Also the effects of particles
on airway inflammation, epithelial permeability and alve-
olar macrophage phagocytic activity have been shown to
vary between mouse strains [37].
The dose-response relationship for particles appeared
similar for BALB/cA and NIH mice, as the low OVA dose
(10 µg) and the high particle doses (40 and 100 µg PSP)
induced the strongest IgE and IgG1 antibody responses.
However, the NIH mice immunized with a high concen-
tration of both OVA and PSP were lost due to anaphylactic
shock after the booster injection. High booster antigen
concentrations have earlier been shown to induce ana-
phylactic shock in mice after subcutaneous priming with
horse gamma globulin covalently bound to cellulose par-
ticles [38]. In mice, IgG(1) has been suggested to be as
effective as IgE in triggering anaphylactic reactions
[39,40]. The induced levels of OVA-specific IgG1
appeared to be about 10 times higher in the surviving NIH
mice than in BALB/cA mice (Figure 1B and 1E). Thus, NIH
mice may be more susceptible than BALB/cA mice to expe-
rience anaphylactic shock either because of a stronger
IgG1 response, or because of an otherwise greater suscep-
tibility to anaphylactic shock.
In the present study, the antibody adjuvant effect of PSP
differed between the different strains of mice, both with
regard to the magnitude and whether a Th2 or a mixed
Th1- and Th2-associated antibody response was
increased. Whereas the Th1-associated IgG2a response
was markedly increased by PSP only in NIH and C3H/
HeN mice, PSP enhanced the Th2-associated IgE response
in all mouse strains examined. PSP seemed also to
increase IgE responses in pilot studies with C57BL/6J and
C3H/HeJ mice (data not shown). Also with regard to the
adjuvant effect of PSP, the BALB/cA mice appeared to be a
high IgE-responder, whereas the C3H/HeN mice seemed
to be a relatively low responder for both OVA-specific IgE
and IgG2a antibody levels. This responder status is in
accordance with other studies of the IgE responsiveness to
OVA in these strains of mice [27,28].
Also with regard to the primary cellular responses in the
lymph node, PSP increased the response to OVA in both
BALB/cA, NIH and C3H/HeN mice (Figure 3). However,
while IL-4 and IL-10 cytokine responses were significantly
increased by OVA+PSP in all three strains, in C3H/HeN
mice the levels were low and the increases may not be bio-
logically significant. On the other hand, OVA+PSP mark-
edly increased the IFN-γ  levels in C3H/HeN mice, and
marginally in BALB/cA mice. IL-4 and IFN-γ  cytokines are
often used as indicators for a Th2 and Thl response,
respectively [41]. In this regard, the cytokine responses to
OVA+PSP could be characterized as Th2-, Th2- and Th1-
biased for BALB/cA, NIH and C3H/HeN mice, respec-
tively, which would not, however, predict the balance
between Th2- and Th1-associated antibody responses
(Figure 1 and 2, see below). Neither could the background
(buffer control) responses for IL-4 and IFN-γ  in the differ-
ent strains explain the balance between Th2- and Th1-
associated antibody responses to OVA+PSP.
The complexity in gene-environment interactions were
illustrated by the highly varying responsiveness to OVA
and PSP given separately in the three strains examined.
BALB/cA mice responded with a non-significant but con-
sistent increase in IL-4 cytokine release in OVA-treated
mice, whereas NIH mice responded with a significantly
increased Th2-biased (IL-4 and IL-10) cytokine release in
PSP-treated mice. C3H/HeN mice responded with both
Th1- and Th2-type cytokine secretion, although appar-
ently Th1-skewed due to low IL-4 and IL-10 levels, after
both OVA or PSP treatments. This suggests that the genetic
background strongly influences the susceptibility to
immunogens and irritative stimuli such as particles, also
with regard to the Th1 and Th2 cytokine balance of the
response. Interestingly, PSP alone increased the Th2-asso-
ciated, but not the Th1-associated, cytokine responses in
NIH mice. If particles by themselves are able to induce IL-
4 production in the lymph nodes also in vivo, this might
promote an allergic response to the allergen present.BMC Immunology 2005, 6:11 http://www.biomedcentral.com/1471-2172/6/11
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Taken together, PSP exerted an adjuvant effect on OVA-
induced IgE and IL-4 levels in all three strains, while there
was no association between the Th1-associated parame-
ters IgG2a and IFN-γ . Thus, for the strains of mice used,
the primary ex vivo cytokine pattern could not predict the
Th2- and Th1-associated antibody pattern. One reason
could be that the Con A-stimulation in vitro was not an
optimal way to describe the actual in vivo cytokine secre-
tion by the PLN cells. However, in vitro OVA-stimulation
of PLN cells from OVA+PSP treated BALB/cA mice gave
similar IL-4 and IFN-γ  response pattern as Con A-stimula-
tion (data not shown). Our findings are consistent with
previous studies showing that cytokine expression was
only in part correlated with airway disease and IgE
responses [35,42], and our data illustrate that interpreta-
tion and extrapolation of in vitro data should be done with
caution. The description of the Th2/Th1 balance may
explain parts of an immune response, however the
immune regulation is more complex, involving other
cytokines, cell surface molecules and regulatory T cells. IL-
10 seems to play an important role in the development
and function of certain regulatory T cells (reviewed in
[43,44]). However, in the present study, IL-10 secretion by
the pool of PLN cells was highly correlated with the secre-
tion of IL-4 (rs = 0.86). Although contribution from regu-
latory T cells could not be excluded, this indicates that IL-
10, which are secreted to a higher degree by Th2 than Th1
cells [45], in the PLN at this stage was produced mainly by
Th2 cells.
In agreement with Randolph et al. [46], we have previ-
ously shown that both PSP, DEP and ambient air particles
in the draining lymph node were located within acid
phosphatase-, MHC class II- and CD86-positive cells,
most probably antigen-presenting cells (APC) [23,47]. It
is remarkable that PSP, in the absence of allergen, affected
the lymph node cells in both NIH and C3H/HeN mice. In
contrast, our present and previous data from BALB/cA
mice indicate that although the particles synergistically
enhanced the cellular responses to OVA, model particles
(PSP, DEP) had no detectable effects neither on PLN cell
numbers, expression of lymphocyte surface molecules nor
on ex vivo cytokine secretion by the PLN cells [23,47].
Taken together, our data from BALB/cA mice therefore
suggest a role for solid particles as allergen carriers [48] in
the adjuvant effect on allergic sensitization. Our present
data suggest that particles, in susceptible strains, addition-
ally influence the immune response in the lymph node. In
our model it appears that the particles which induced cel-
lular responses in the absence of allergen (i.e. ambient air
particles in BALB/cA mice [47] as well as PSP in NIH and
C3H/HeN mice (present study)) enhanced both Th2- and
Th1-associated antibody responses, whereas the particles
enhancing a Th2-dominated antibody response (i.e. PSP
and DEP in BALB/cA mice) did not induce detectable cel-
lular changes themselves. This suggests that the insoluble
particle core act by enhancing the inherent response to the
allergen (acts like a "general motor" [6]), and that genetic
background and particle properties determine whether an
additional Th1-associated response is elicited. The
presence of a Th1 response has been suggested to amplify
Th2-driven inflammation [49-52]. Our results therefore
suggest that particles may both enhance the IgE sensitiza-
tion and, depending on genetically determined suscepti-
bility, further aggravate allergic inflammation and thereby
increase the allergic symptoms in some individuals.
Conclusion
PSP enhanced the OVA-specific IgE antibody responses in
all strains of mice examined, whereas the IgG2a response
was increased to varying degrees and only in some strains.
Genetic factors (i.e. the strain of mice) influenced the
responsiveness to the adjuvant effect of PSP on secondary
antibody responses and the primary cellular responses to
OVA. Furthermore, genetic factors also influenced the
lymph node cell responsiveness to both OVA and PSP
given separately. Interestingly, PSP alone induced differ-
ent cytokine responses in the lymph node in some of the
mouse strains. Furthermore, we found that the ex vivo
cytokine patterns could not predict the in vivo Th2- and
Th1-associated antibody response patterns in the different
mouse strains. The results indicate that the insoluble par-
ticle core acts by increasing the inherent response to the
allergen, and that the genetic background may determine
whether an additional Th1-associated component is
added.
Methods
Animals
Female inbred BALB/cABomTac and BALB/cJBomTac
mice (Taconic M&B A/S, Ry, Denmark) and NIH/OlaHsd
and C3H/HeNHsd mice (Harlan UK Ltd., Oxon, UK) were
used. The mice were housed, 5–8 animals per cage, on
BeeKay bedding (B&K Universal AS, Nittedal, Norway) in
type III macrolon cages in filter cabinets (Scantainers).
The animals were allowed to rest for at least one week
before entering the experiments 6–7 weeks old. The mice
were exposed to a 12-hr/12-hr light/dark cycle (30–60 lux
in cages), room temperature (20 ± 2°C) and 40–60% rel-
ative humidity. The animals were given pelleted food
(RM1, SDS, Essex, UK) and tap water ad libitum. The exper-
iments were performed in conformity with the laws and
regulations for experiments with live animals in Norway,
and they were approved by the Experimental Animal
Board under the Ministry of Agriculture in Norway.
Particles and allergen
As a surrogate for the insoluble particle core of combus-
tion particles, polystyrene particles (PSP) with a diameter
of 0.1 µm were used (Polybead Polystyrene Microspheres;BMC Immunology 2005, 6:11 http://www.biomedcentral.com/1471-2172/6/11
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Polysciences Europe GmbH, Eppelheim, Germany). As
allergen, ovalbumin (OVA, Gal d 2; chicken egg albumin,
grade VII, Sigma, St. Louis, MO, USA) was used. In the
dose-response experiments, we used particle doses of 100,
40 and 10 µg per injection (14.9, 5.94 and 1.49 × 1010 par-
ticles, respectively), as well as OVA doses of 100, 50 and
10 µg per injection. For all further studies, the dose of 40
µg PSP (5.94 × 1010 particles) and 10 µg OVA per injection
was used. All preparations were made in Hank's balanced
salt solution (HBSS; PAA Laboratories GmbH, Linz, Aus-
tria). 20 µl of the different preparations were injected sub-
cutaneously into the hind footpad (heal-toe direction)
using a 100 µl Hamilton syringe (Hamilton Bonaduz AG,
Switzerland) with a 30 G sterile needle (BD Medical Sys-
tems, Ireland).
Experimental design
Dose response experiments were performed in groups of
eight BALB/cA or NIH mice, with all combinations of 100,
40, 10 and 0 µg PSP and 100, 50 and 10 µg OVA. The sus-
pensions were injected into the right hind footpad on day
0, and a booster with the same OVA dose was given on day
21. On day 26, the mice were exsanguinated by heart
puncture under CO2 anesthesia. Serum was stored at -
20°C until analyzed. Serum levels of OVA-specific IgE,
IgG1 and IgG2a were measured by enzyme-linked immu-
nosorbent assay (ELISA). Next, to further examine the
qualitative differences in the adjuvant effect of particles,
antibody responses after injection of OVA+PSP, OVA, PSP
and buffer (HBSS) were determined in the mouse strains
NIH, BALB/cA and BALB/cJ, and in a separate experiment
in C3H/HeN. These experiments were all performed
twice, with eight mice per group.
In a model previously described [23], we studied the pri-
mary cellular response in the draining lymph node in
BALB/cA, NIH and C3H/HeN mice (fifteen mice per
group). The popliteal lymph nodes (PLN) were excised
five days after injection into both hind footpads of OVA
and PSP, separately or in combination. After pooling of
the PLN from the same animal, the total cell numbers per
PLN were determined (Coulter Counter). Thereafter, PLN
cells from five animals were pooled to achieve sufficient
cell numbers per well for ex vivo culture with Con A, and
the cytokine concentrations in cell culture supernatants
were determined by sandwich ELISAs. In one set of exper-
iments, the responses of cells from OVA and OVA+PSP
treated animals from all strains were determined, and
untreated mice were studied in a separate experiment. A
confirming set of experiments was then conducted, this
time performed in separate experiments for each strain of
mice (the results shown in Figure 3).
ELISA for detection of IgE, IgG1 and IgG2a anti-OVA 
antibodies
IgE, IgG1 and IgG2a anti-OVA antibodies were detected in
a capture ELISAs as previously described [19,53], as mod-
ified in [54]. In short, microtiter plates coated with a mon-
oclonal rat anti-mouse IgE, rat anti-mouse IgG1 or rat
anti-mouse IgG2a antibody were incubated with the
mouse sera in triplicates, diluted 1:10, 1:20 and 1:20,
respectively. After incubation with biotinylated OVA, fol-
lowed by incubation with pre-formed complexes of
streptavidin and biotinylated alkaline phosphatase, p-
nitrophenyl phosphate disodiumhexahydrat diluted in a
diethanolamine buffer was added as substrate. Dilutions
of a standard mouse OVA-immune serum pool were
included on each plate for standard curve production. OD
was measured at 405 nm on a MRX Microplate Reader
(Dynatech Laboratories, Chantilly, VA, USA) connected to
a PC using BioLinx software (Dynatech Laboratories), and
the antibody concentrations are given in arbitrary units
(AU) per ml.
PLN single cell suspensions and ex vivo cytokine secretion 
after Con A stimulation
Five days after injection, the popliteal lymph nodes were
excised and single cell suspensions prepared as previously
described [23]. After pooling of the two PLN cell suspen-
sions from the same animal, the cell concentration was
measured with a Coulter Counter Z1 (Beckman Coulter
Incorporated, FL, USA), and presented as the total cell
number (106) per PLN. Thereafter, as described elsewhere
[23], the PLN cells were cultured with 5 µg/ml Concanav-
alin A (Con A, Sigma, MO, USA), and ex vivo IL-4, IFN-γ
and IL-10 cytokine secretion into the culture supernatants
was determined by Mouse DuoSets ELISA (R&D Systems
Inc., MN, USA). The optimal incubation times for the
measurement of IL-4, IFN-γ  and IL-10 with BALB/cA mice
were previously found to be 24, 48 and 24 hours, respec-
tively [23], and data for these time points are presented.
Statistical analysis
Statistical analysis was performed with SigmaStat ® Statis-
tical Analysis System for Windows Version 2.03 (Jandel
Scientific, Erkrath, Germany). Antibody levels, cell num-
bers and cytokine levels were log10-transformed to achieve
normally distributed data with equal variances. In the
dose-response experiments in BALB/cA mice, the data
were analyzed in a two way ANOVA, using "OVA dose" as
factor 1 and "PSP dose" as factor 2. Due to lost animals in
the experiment with NIH mice, similar analyses could not
be performed, and a one way ANOVA was run only on the
data with 10 µg OVA. In both strains, the pair-wise com-
parisons were performed using Tukey's post hoc test. In all
other experiments, to assure equal criteria for all strains
independent of experimental size/setup, the data from
each strain of mice were analyzed separately, using a par-BMC Immunology 2005, 6:11 http://www.biomedcentral.com/1471-2172/6/11
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ametric one way ANOVA. If the ANOVAs showed statisti-
cal differences with a significance of p ≤  0.05, pair-wise
comparisons of all groups within each mouse strain were
performed by Tukey's post hoc test. Experimental groups
were considered statistically different if p ≤  0.05, and dif-
ferences found statistically significant in two experiments
are indicated in the figures.
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